Microsoft’s head of research and his colleagues believe chatbots will be used by medical professionals, as well as by patients, with increasing frequency.
Peter Lee could use some rest.
Microsoft’s (MSFT) – Get Free Report head of research has been missing out on some shuteye after spending time with OpenAI’s GPT-4, the AI-powered tool that simulates human conversation.
The software giant has invested more than $10 billion in the startup and Lee has invested a lot of time with GPT4.
“I lost a couple weeks of sleep,” Lee during a March 27 lecture at the University of Washington, according to GeekWire. “It was very intense.”
Lee is tasked with assessing the implications of the tool for medicine. He believes it could increase efficiency and even empathy in the healthcare system, as well as boost biomedical research.
GPT-4 has “amazing capabilities” Lee said during his lecture. And “ends up being a really potentially useful tool” for medicine.
